dilluns, 18 de maig del 2015

OrbusNeich launches U.S. pivotal for Combo stent

OrbusNeich enrolls the 1st U.S. patient in a pivotal trial of its Combo dual-therapy coronary stent.

OrbusNeich launches U.S. pivotal for Combo stent

OrbusNeich Medical said today that it enrolled the 1st U.S. patient in a pivotal trial of its dual-therapy Combo stent.

OrbusNeich
News Well, Clinical Trials, Stents

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1IMxEQB
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)